This inventor holds 1 USPTO granted patent. Top assignee: University of Kentucky Research Foundation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Dagmar Noskova: Innovator in Controlled Release Capsule Technology
Introduction
Dagmar Noskova is a prominent inventor based in Lexington, KY (US). She has made significant contributions to the field of pharmaceutical delivery systems. Her innovative work focuses on developing advanced capsule technologies that enhance the efficacy of drug delivery.
Latest Patents
Noskova holds a patent for a multicompartment hard capsule with controlled release properties. This invention relates to a hard capsule made from materials such as gelatin, starch, or hydrophilic polymers. The capsule is designed as a delivery system that incorporates pharmacologically active components in three or more distinct compartments. The outer compartment contains a drug and excipients, representing the rapid release portion of the system. The intermediate compartment comprises a powder formulation that serves as the intermediary speed release portion. Finally, the innermost compartment includes the active ingredient in a multiparticulate form, representing the slow release component of the delivery system. She has 1 patent to her name.
Career Highlights
Noskova is affiliated with the University of Kentucky Research Foundation, where she continues to advance her research in pharmaceutical technologies. Her work has garnered attention for its potential to improve patient outcomes through more effective drug delivery methods.
Collaborations
One of her notable collaborators is George A. Digenis, with whom she has worked on various projects related to her patent.
Conclusion
Dagmar Noskova's contributions to the field of controlled release capsule technology highlight her innovative spirit and dedication to improving pharmaceutical delivery systems. Her work continues to pave the way for advancements in drug formulation and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
